<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Van Gucht I</submitter><funding>British Heart Foundation</funding><funding>European Research Council</funding><funding>Universiteit Antwerpen</funding><funding>Fonds Wetenschappelijk Onderzoek</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Dutch Heart Foundation</funding><funding>European 398 Reference Network on rare multisystemic vascular disorders</funding><pagination>7111</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8269155</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(13)</volume><pubmed_abstract>Thoracic aortic aneurysm and dissection (TAAD) is a major cause of cardiovascular morbidity and mortality. Loss-of-function variants in &lt;i>LOX&lt;/i>, encoding the extracellular matrix crosslinking enzyme lysyl oxidase, have been reported to cause familial TAAD. Using a next-generation TAAD gene panel, we identified five additional probands carrying &lt;i>LOX&lt;/i> variants, including two missense variants affecting highly conserved amino acids in the &lt;i>LOX&lt;/i> catalytic domain and three truncating variants. Connective tissue manifestations are apparent in a substantial fraction of the variant carriers. Some &lt;i>LOX&lt;/i> variant carriers presented with TAAD early in life, while others had normal aortic diameters at an advanced age. Finally, we identified the first patient with spontaneous coronary </pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Novel &lt;i>LOX&lt;/i> Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings.</pubmed_title><pmcid>PMC8269155</pmcid><funding_grant_id>PG/13/96/30608</funding_grant_id><funding_grant_id>1S81820N</funding_grant_id><funding_grant_id>2013T093</funding_grant_id><funding_grant_id>FFB190208</funding_grant_id><funding_grant_id>G042321N</funding_grant_id><funding_grant_id>NF-SI-0611-10170</funding_grant_id><funding_grant_id>771945</funding_grant_id><funding_grant_id>ERC-COG-2017-771945)</funding_grant_id><funding_grant_id>G044720N</funding_grant_id><funding_grant_id>12X8520N</funding_grant_id><funding_grant_id>769036</funding_grant_id><funding_grant_id>1S70419N</funding_grant_id><funding_grant_id>G040221N,</funding_grant_id><pubmed_authors>Adlam D</pubmed_authors><pubmed_authors>Macek M</pubmed_authors><pubmed_authors>Loeys BL</pubmed_authors><pubmed_authors>Krebsova A</pubmed_authors><pubmed_authors>Verstraeten A</pubmed_authors><pubmed_authors>Diness BR</pubmed_authors><pubmed_authors>Perik M</pubmed_authors><pubmed_authors>Votypka P</pubmed_authors><pubmed_authors>Samani NJ</pubmed_authors><pubmed_authors>Van Laer L</pubmed_authors><pubmed_authors>Meester J</pubmed_authors><pubmed_authors>Laga S</pubmed_authors><pubmed_authors>Peeters N</pubmed_authors><pubmed_authors>Van Den Heuvel L</pubmed_authors><pubmed_authors>Van Gucht I</pubmed_authors><pubmed_authors>Kempers M</pubmed_authors><pubmed_authors>Webb TR</pubmed_authors><pubmed_authors>Luyckx I</pubmed_authors><pubmed_authors>Baranowska AA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel &lt;i>LOX&lt;/i> Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings.</name><description>Thoracic aortic aneurysm and dissection (TAAD) is a major cause of cardiovascular morbidity and mortality. Loss-of-function variants in &lt;i>LOX&lt;/i>, encoding the extracellular matrix crosslinking enzyme lysyl oxidase, have been reported to cause familial TAAD. Using a next-generation TAAD gene panel, we identified five additional probands carrying &lt;i>LOX&lt;/i> variants, including two missense variants affecting highly conserved amino acids in the &lt;i>LOX&lt;/i> catalytic domain and three truncating variants. Connective tissue manifestations are apparent in a substantial fraction of the variant carriers. Some &lt;i>LOX&lt;/i> variant carriers presented with TAAD early in life, while others had normal aortic diameters at an advanced age. Finally, we identified the first patient with spontaneous coronary </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-04-08T07:23:04.742Z</modification><creation>2026-04-07T23:40:52.6Z</creation></dates><accession>S-EPMC8269155</accession><cross_references><pubmed>34281165</pubmed><doi>10.3390/ijms22137111</doi></cross_references></HashMap>